Buy Lupin, target Rs 782: Kunal Bothra


Buy Lupin Ltd. at a price target of Rs 782.0 and a stoploss at Rs 745 from entry point.|


Updated: Dec 10, 2019, 08.58 AM IST


ThinkStock Photos


Independent analyst Kunal Bothra has a buy call on Lupin Ltd. with a target price of Rs 782. The current market price of Lupin Ltd. is Rs 755.45. Time period given by the analyst is Intra Day when Lupin Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 745. Lupin Ltd., incorporated in 1983, has a market cap of Rs 34201.85 crore.

Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10657.32 Crore to Sales Value (93.84 % of Total Sales), Other Services which contributed Rs 374.24 Crore to Sales Value (3.29 % of Total Sales), Export Incentives which contributed Rs 250.66 Crore to Sales Value (2.20 % of Total Sales) and Other Operating Revenue which contributed Rs 74.10 Crore to Sales Value (0.65 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4296.90 Crore, down -1.35 % from last quarter Sales of Rs 4355.83 Crore and up 10.43 % from last year same quarter Sales of Rs 3890.93 Crore Company has reported net profit after tax of Rs -124.40 Crore in latest quarter. The company’s top management includes Dr.K U Mada, Dr.Kamal K Sharma, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Deshbandhu Gupta, Mr.R A Shah, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Christine Mundkur, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditors. As on 30-06-2019, the company has a total of 452,590,752 shares outstanding.

Also Read

Buy Lupin, target Rs 805: Kunal Bothra

Buy ITC, target Rs 260: Kunal Bothra

Buy BHEL, target Rs 62: Kunal Bothra


Bet on Bank Nifty if it corrects further: Kunal Bothra

Sell DLF, target Rs 175: Kunal Bothra

Commenting feature is disabled in your country/region.

Disclaimer: This recommendation is analyst’s own and does not represent those of & Please consult your financial advisor before taking any position in the stock/s mentioned.

Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Read More



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: